Determination of the sensitivity of diverse SARS-CoV-2 antibodyassays in patients with proven SARS-CoV-2 infection but mild symptoms.
ID
Source
Brief title
Condition
- Viral infectious disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Sensitivity of the diverse assays in a population of patients with mild
symptoms.
Secondary outcome
not applicable
Background summary
The SARS-CoV-2 virus is spread all around the world. The presence of the virus
can be demonstrated in nasal swabs by PCR. However antibody testing for this
virus is important to prove if a patient has had the disease in the previous
period. A lot of commercial assays are nowadays on the market and
assaycharacteristics should be determined especially in patients with mild
symptoms.
Study objective
Determination of the sensitivity of diverse SARS-CoV-2 antibodyassays in
patients with proven SARS-CoV-2 infection but mild symptoms.
Study design
Patients with a positive PCR in their nasal swab who are not hospitalized, are
recruited. Blood is drawn by venapuncture. The samples are tested in diverse
available antibodyassays.
Study burden and risks
There is no extra risk other than the risk of a venous bloodsampling. The
sampling will be done by experienced personell.
Koningsplein 1
Enschede 7500 KA
NL
Koningsplein 1
Enschede 7500 KA
NL
Listed location countries
Age
Inclusion criteria
18 years or older
Abliity to read and understand informed consent
Proven SARS-CoV-2 infection more than three weeks ago.
No hospitalisation for more than three month
No clinical symptoms of active infection at the time of bloodsampling
Exclusion criteria
age of 17 years or younger
Unable to read the informed consent
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL74124.100.20 |